V

Valion Bio Inc.
D

VBIO

0.12300
USD
-0.01
(-8.82%)
Post Trading·0.12100USD-0.00200(-1.63%)
حجم التداول
3,150
الربح لكل سهم
-24
العائد الربحي
-
P/E
-0
حجم السوق
510,605
المقالات
المزيد

العنوان: Valion Bio Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.